Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Production of isotopes using high power proton beams

Patent ·
OSTI ID:1345367

The invention provides for a method for producing isotopes using a beam of particles from an accelerator, whereby the beam is maintained at between about 70 to 2000 MeV; and contacting a thorium-containing target with the particles. The medically important isotope .sup.225Ac is produced via the nuclear reaction (p,2p6n), whereby an energetic proton causes the ejection of 2 protons and 6 neutrons from a .sup.232Th target nucleus. Another medically important isotope .sup.213Bi is then available as a decay product. The production of highly purified .sup.211At is also provided.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-06CH11357
Assignee:
UCHICAGO ARGONNE, LLC (Chicago, IL)
Patent Number(s):
9,202,602
Application Number:
13/025,079
OSTI ID:
1345367
Country of Publication:
United States
Language:
English

References (6)

Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies journal October 2007
Production of Ac-225 from Th-229 for Targeted α Therapy journal October 2005
Cancer Therapy with Alpha-Emitters Labeled Peptides journal May 2010
Production of 225Ac and 223Ra by irradiation of Th with accelerated protons journal February 2011
Spallation of Uranium and Thorium Nuclei with Bev-Energy Protons journal July 1961
Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins journal November 2006

Related Subjects